1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Global Orphan Drugs Industry 2015 Market Research Report

Global Orphan Drugs Industry 2015 Market Research Report

  • November 2015
  • -
  • QY Research Group
  • -
  • 153 pages

Summary


The Global Orphan Drugs Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Orphan Drugs industry.

The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Orphan Drugs market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status.

Development policies and plans are discussed as well as manufacturing processes and cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins.

The report focuses on global major leading industry players providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out.The Orphan Drugs industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered.

With 174 tables and figures the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

Table Of Contents

Global Orphan Drugs Industry 2015 Market Research Report
Table of Contents

1 Industry Overview
1.1 Definition and Specifications of Orphan Drugs
1.1.1 Definition of Orphan Drugs
1.1.2 Specifications of Orphan Drugs
1.2 Classification of Orphan Drugs
1.3 Applications of Orphan Drugs
1.4 Industry Chain Structure of Orphan Drugs
1.5 Industry Overview and Major Regions Status of Orphan Drugs
1.5.1 Industry Overview of Orphan Drugs
1.5.2 Global Major Regions Status of Orphan Drugs
1.6 Industry Policy Analysis of Orphan Drugs
1.7 Industry News Analysis of Orphan Drugs

2 Manufacturing Cost Structure Analysis of Orphan Drugs
2.1 Raw Material Suppliers and Price Analysis of Orphan Drugs
2.2 Equipment Suppliers and Price Analysis of Orphan Drugs
2.3 Labor Cost Analysis of Orphan Drugs
2.4 Other Costs Analysis of Orphan Drugs
2.5 Manufacturing Cost Structure Analysis of Orphan Drugs
2.6 Manufacturing Process Analysis of Orphan Drugs
2.7 Global Price, Cost and Gross of Orphan Drugs 2010-2015

3 Technical Data and Manufacturing Plants Analysis of Orphan Drugs
3.1 Capacity and Commercial Production Date of Global Key Manufacturers in 2014
3.2 Manufacturing Plants Distribution of Global Key Orphan Drugs Manufacturers in 2014
3.3 RandD Status and Technology Source of Global Orphan Drugs Key Manufacturers in 2014
3.4 Raw Materials Sources Analysis of Global Orphan Drugs Key Manufacturers in 2014

4 Production Analysis of Orphan Drugs by Regions, Type, and Applications
4.1 Global Production of Orphan Drugs by Regions 2010-2015
4.2 Global Production of Orphan Drugs by Type 2010-2015
4.3 Global Production of Orphan Drugs by Applications 2010-2015
4.4 Price Analysis of Global Orphan Drugs Key Manufacturers in 2015
4.5 US Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Orphan Drugs 2010-2015
4.6 EU Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Orphan Drugs 2010-2015
4.7 Japan Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Orphan Drugs 2010-2015
4.8 China Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Orphan Drugs 2010-2015

5 Consumption Volume and Consumption Value Analysis of Orphan Drugs by Regions
5.1 Global Consumption Volume of Orphan Drugs by Regions 2010-2015
5.2 Global Consumption Value of Orphan Drugs by Regions 2010-2015
5.3 Global Consumption Price Analysis of Orphan Drugs by Regions 2010-2015

6 Analysis of Orphan Drugs Production, Supply, Sales and Market Status 2010-2015
6.1 Capacity and Production of Orphan Drugs 2010-2015
6.2 Production Market Share Analysis of Orphan Drugs 2010-2015
6.3 Sales Overview of Orphan Drugs 2010-2015
6.4 Supply, Sales and Gap of Orphan Drugs 2010-2015
6.5 Import, Export and Consumption of Orphan Drugs 2010-2015
6.6 Cost, Price, Revenue and Gross Margin of Orphan Drugs 2010-2015

7 Analysis of Orphan Drugs Industry Key Manufacturers
7.1 Novartis
7.1.1 Company Profile
7.1.2 Product Picture and Specification
7.1.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.1.4 Contact Information

7.2 Roche
7.2.1 Company Profile
7.2.2 Product Picture and Specification
7.2.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.2.4 Contact Information

7.3 Celgene
7.3.1 Company Profile
7.3.2 Product Picture and Specification
7.3.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.3.4 Contact Information

7.4 Pfizer
7.4.1 Company Profile
7.4.2 Product Picture and Specification
7.4.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.4.4 Contact Information

7.5 Sanofi
7.5.1 Company Profile
7.5.2 Product Picture and Specification
7.5.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.5.4 Contact Information

8 Price and Gross Margin Analysis of Orphan Drugs
8.1 Analysis of Price, Supply and Consumption
8.1.1 Price Analysis
8.1.2 Supply Analysis
8.2 Gross Margin Analysis
8.3 Price Comparison by Regions
8.4 Price Analysis of Different Orphan Drugs Product Types
8.5 Market Share Analysis of Different Orphan Drugs Price Levels
8.6 Gross Margin Analysis of Different Orphan Drugs Applications

9 Marketing Trader or Distributor Analysis of Orphan Drugs
9.1 Marketing Channels Status of Orphan Drugs
9.2 Traders or Distributors of Orphan Drugs with Contact Information
9.3 Ex-work Price, Channel Price and End Buyer Price Analysis of Orphan Drugs
9.4 Regional Import, Export and Trade Analysis of Orphan Drugs

10 Development Trend of Orphan Drugs Industry 2016-2021
10.1 Capacity and Production Overview of Orphan Drugs 2016-2021
10.2 Production Market Share Analysis of Orphan Drugs 2016-2021
10.3 Sales Overview of Orphan Drugs 2016-2021
10.4 Supply, Sales, and Gap of Orphan Drugs 2016-2021
10.5 Import, Export and Consumption of Orphan Drugs 2016-2021
10.6 Cost, Price, Revenue and Gross Margin of Orphan Drugs 2016-2021

11 Industry Chain Suppliers with Contact Information of Orphan Drugs
11.1 Major Raw Materials Suppliers with Contact Information of Orphan Drugs Industry
11.2 Manufacturing Equipment Suppliers of Orphan Drugs with Contact Information
11.3 Major Suppliers of Orphan Drugs with Contact Information
11.4 Key Consumers of Orphan Drugs with Contact Information
11.5 Supply Chain Relationship Analysis of Orphan Drugs

12 New Project Investment Feasibility Analysis of Orphan Drugs
12.1 New Project SWOT Analysis of Orphan Drugs
12.2 New Project Investment Feasibility Analysis of Orphan Drugs

13 Conclusion of the Global Orphan Drugs Industry 2015 Market Research Report




List of Tables and Figures
Figure Picture of Orphan Drugs
Table Specifications of Orphan Drugs
Table Classification of Orphan Drugs
Figure Global Production Market Share of Orphan Drugs by Type in 2015
Table Application Fields of Orphan Drugs Products
Figure 2015 Global Orphan Drugs Major Applications Sales Share
Figure Industry Chain Structure of Orphan Drugs
Table Global Major Regions Orphan Drugs Development Status
Table Industry Policy of Orphan Drugs
Table Industry News List of Orphan Drugs
Table Orphan Drugs Major Raw Materials List
Table Manufacturing Cost Structure Analysis of Orphan Drugs in 2014
Figure Manufacturing Process Analysis of Orphan Drugs
Figure Global Price Analysis of Orphan Drugs 2010-2015 (USD/Dose)
Figure Global Cost Analysis of Orphan Drugs 2010-2015 (USD/Dose)
Figure Global Gross Analysis of Orphan Drugs 2010-2015
Table Capacity (Doses) and Commercial Production Date of Global Orphan Drugs Key Manufacturers in 2014
Table Manufacturing Plants Distribution of Global Key Orphan Drugs Manufacturers in 2014
Table RandD Status and Technology Source of Global Orphan Drugs Key Manufacturers in 2014
Table Raw Materials Sources Analysis of Global and China Orphan Drugs Key Manufacturers in 2014
Table Global Production of Orphan Drugs by Regions 2010-2015 (Doses)
Figure Global Production Market Share of Orphan Drugs by Regions in 2014
Table Global Production of Orphan Drugs by Type 2010-2015 (Doses)
Figure Global Production Market Share of Orphan Drugs by Type in 2014
Table Global Production of Orphan Drugs by Applications 2010-2015 (Doses)
Figure Global Production Market Share of Orphan Drugs by Applications in 2014
Figure Price Comparison of Global Orphan Drugs Key Manufacturers in 2015 (USD/Dose)
Table US Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Revenue (M USD) and Gross Margin of Orphan Drugs 2010-2015
Table US Supply, Import, Export and Consumption of Orphan Drugs 2010-2015 (Doses)
Table EU Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Revenue (M USD) and Gross Margin of Orphan Drugs 2010-2015
Table EU Supply, Import, Export and Consumption of Orphan Drugs 2010-2015 (Doses)
Table Japan Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Revenue (M USD) and Gross Margin of Orphan Drugs 2010-2015
Table Japan Supply, Import, Export and Consumption of Orphan Drugs 2010-2015 (Doses)
Table China Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Revenue (M USD) and Gross Margin of Orphan Drugs 2010-2015
Table China Supply, Import, Export and Consumption of Orphan Drugs 2010-2015 (Doses)
Table Global Consumption Volume of Orphan Drugs by Regions 2010-2015 (Doses)
Figure Global Consumption Volume of Orphan Drugs by Regions in 2010 (Doses)
Figure Global Consumption Volume of Orphan Drugs by Regions in 2011 (Doses)
Figure Global Consumption Volume of Orphan Drugs by Regions in 2012 (Doses)
Figure Global Consumption Volume of Orphan Drugs by Regions in 2013 (Doses)
Figure Global Consumption Volume of Orphan Drugs by Regions in 2014 (Doses)
Figure Global Consumption Volume of Orphan Drugs by Regions in 2015 (Doses)
Table Global Consumption Value of Orphan Drugs by Regions 2010-2015 (M USD)
Figure Global Consumption Value of Orphan Drugs by Regions in 2010 (M USD)
Figure Global Consumption Value of Orphan Drugs by Regions in 2011 (M USD)
Figure Global Consumption Value of Orphan Drugs by Regions in 2012 (M USD)
Figure Global Consumption Value of Orphan Drugs by Regions in 2013 (M USD)
Figure Global Consumption Value of Orphan Drugs by Regions in 2014 (M USD)
Figure Global Consumption Value of Orphan Drugs by Regions in 2015 (M USD)
Table Consumption Price of Orphan Drugs by Regions 2010-2015 (USD/Dose)
Table Global and Major Manufacturers Capacity of Orphan Drugs 2010-2015 (Doses)
Table Global Capacity Market Share of Major Orphan Drugs Manufacturers 2010-2015
Table Global and Major Manufacturers Production of Orphan Drugs 2010-2015 (Doses)
Table Global Production Market Share of Major Orphan Drugs Manufacturers 2010-2015
Figure Global Capacity (Doses), Production (Doses) and Growth Rate of Orphan Drugs 2010-2015
Figure Global Capacity Utilization Rate of Orphan Drugs 2010-2015
Table Global and Major Manufacturers Revenue of Orphan Drugs 2010-2015 (M USD)
Table Global Revenue Market Share of Major Orphan Drugs Manufacturers 2010-2015
Figure Global Revenue (M USD) and Growth Rate of Orphan Drugs 2010-2015
Table China and Major Manufacturers Capacity of Orphan Drugs 2010-2015 (Doses)
Table Capacity Market Share of China Major Orphan Drugs Manufacturers 2010-2015
Table China and Major Manufacturers Production of Orphan Drugs 2010-2015 (Doses)
Table Production Market Share of China Major Orphan Drugs Manufacturers 2010-2015
Figure China Capacity (Doses), Production (Doses) and Growth Rate of Orphan Drugs 2010-2015
Figure China Capacity Utilization Rate of Orphan Drugs 2010-2015
Table China and Major Manufacturers Revenue of Orphan Drugs 2010-2015 (M USD)
Table Revenue Market Share of China Major Manufacturers 2010-2015
Figure China Revenue (M USD) and Growth Rate of Orphan Drugs 2010-2015
Figure Global Production Market Share of Major Orphan Drugs Manufacturers in 2010
Figure Global Production Market Share of Major Orphan Drugs Manufacturers in 2011
Figure Global Production Market Share of Major Orphan Drugs Manufacturers in 2012
Figure Global Production Market Share of Major Orphan Drugs Manufacturers in 2013
Figure Global Production Market Share of Major Orphan Drugs Manufacturers in 2014
Figure Global Production Market Share of Major Orphan Drugs Manufacturers in 2015
Figure China Production Market Share of Major Orphan Drugs Manufacturers in 2010
Figure China Production Market Share of Major Orphan Drugs Manufacturers in 2011
Figure China Production Market Share of Major Orphan Drugs Manufacturers in 2012
Figure China Production Market Share of Major Orphan Drugs Manufacturers in 2013
Figure China Production Market Share of Major Orphan Drugs Manufacturers in 2014
Figure China Production Market Share of Major Orphan Drugs Manufacturers in 2015
Figure Global Sales (Doses) and Growth Rate of Orphan Drugs 2010-2015
Figure China Sales (Doses) and Growth Rate of Orphan Drugs 2010-2015
Table Global Supply, Sales and Gap of Orphan Drugs 2010-2015 (Doses)
Table China Supply, Sales and Gap of Orphan Drugs 2010-2015 (Doses)
Table China Import, Export and Consumption of Orphan Drugs 2010-2015 (Doses)
Table Price of Global Orphan Drugs Major Manufacturers 2010-2015 (USD/Dose)
Figure Price Comparison by Global Major Orphan Drugs Manufacturers in 2014 (USD/Dose)
Table Gross Margin of Global Orphan Drugs Major Manufacturers 2010-2015
Figure Gross Margin of Global Orphan Drugs Major Manufacturers in 2014
Table Global and Major Manufacturers Revenue of Orphan Drugs 2010-2015 (M USD)
Table Global Revenue Market Share of Major Orphan Drugs Manufacturers 2010-2015
Figure Global Revenue Market Share of Major Orphan Drugs Manufacturers in 2011
Figure Global Revenue Market Share of Major Orphan Drugs Manufacturers in 2012
Figure Global Revenue Market Share of Major Orphan Drugs Manufacturers in 2013
Figure Global Revenue Market Share of Major Orphan Drugs Manufacturers in 2014
Figure Global Revenue Market Share of Major Orphan Drugs Manufacturers in 2015
Table China and Major Manufacturers Revenue of Orphan Drugs 2010-2015 (M USD)
Table Revenue Market Share of China Orphan Drugs Major Manufacturers 2010-2015
Table Global Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Revenue (M USD) and Gross Margin of Orphan Drugs 2010-2015
Table China Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Revenue (M USD) and Gross Margin of Orphan Drugs 2010-2015
Figure Orphan Drugs Picture and Specifications of Novartis
Table Orphan Drugs Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Novartis 2010-2015
Figure Orphan Drugs Capacity (Doses), Production (Doses) and Growth Rate of Novartis 2010-2015
Figure Orphan Drugs Production (Doses) and Global Market Share of Novartis 2010-2015
Figure Orphan Drugs Picture and Specifications of Roche
Table Orphan Drugs Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Roche 2010-2015
Figure Orphan Drugs Capacity (Doses), Production (Doses) and Growth Rate of Roche 2010-2015
Figure Orphan Drugs Production (Doses) and Global Market Share of Roche 2010-2015
Figure Orphan Drugs Picture and Specifications of Celgene
Table Orphan Drugs Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Celgene 2010-2015
Figure Orphan Drugs Capacity (Doses), Production (Doses) and Growth Rate of Celgene 2010-2015
Figure Orphan Drugs Production (Doses) and Global Market Share of Celgene 2010-2015
Figure Orphan Drugs Picture and Specifications of Pfizer
Table Orphan Drugs Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Pfizer 2010-2015
Figure Orphan Drugs Capacity (Doses), Production (Doses) and Growth Rate of Pfizer 2010-2015
Figure Orphan Drugs Production (Doses) and Global Market Share of Pfizer 2010-2015
Figure Orphan Drugs Picture and Specifications of Sanofi
Table Orphan Drugs Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Sanofi 2010-2015
Figure Orphan Drugs Capacity (Doses), Production (Doses) and Growth Rate of Sanofi 2010-2015
Figure Orphan Drugs Production (Doses) and Global Market Share of Sanofi 2010-2015
Table Gross Margin of Orphan Drugs by Regions 2010-2015
Table Price Comparison of Orphan Drugs by Regions 2010-2015 (USD/Dose)
Table Price of Different Orphan Drugs Product Types (USD/Dose)
Table Market Share of Different Orphan Drugs Price Level
Table Gross Margin of Different Orphan Drugs Applications
Table Traders or Distributors of Orphan Drugs with Contact Information
Table Ex-work Price, Channel Price and End Buyer Price of Orphan Drugs (USD/Dose)
Table Regional Import, Export, and Trade of Orphan Drugs (Doses)
Figure Global Capacity (Doses), Production (Doses) and Growth Rate of Orphan Drugs 2016-2021
Figure Global Capacity Utilization Rate of Orphan Drugs 2016-2021
Figure China Capacity (Doses), Production (Doses) and Growth Rate of Orphan Drugs 2016-2021
Figure China Capacity Utilization Rate of Orphan Drugs 2016-2021
Figure Global Production Market Share of Major Orphan Drugs Manufacturers in 2016
Figure Global Production Market Share of Major Orphan Drugs Manufacturers in 2021
Figure Production Market Share of China Major Orphan Drugs Manufacturers in 2016
Figure Production Market Share of China Major Orphan Drugs Manufacturers in 2021
Figure Global and China Sales (Doses) and Growth Rate of Orphan Drugs 2016-2021
Table Global Supply, Sales and Gap of Orphan Drugs 2016-2021 (Doses)
Table China Supply, Sales and Gap of Orphan Drugs 2016-2021 (Doses)
Table China Production, Import, Export and Consumption of Orphan Drugs 2016-2021 (Doses)
Table Global Production (Doses), Price (USD/Dose), Cost (USD/Dose), Revenue (M USD) and Gross Margin of Orphan Drugs 2016-2021
Table China Production (Doses), Price (USD/Dose), Cost (USD/Dose), Revenue (M USD) and Gross Margin of Orphan Drugs 2016-2021
Table Major Raw Materials Suppliers with Contact Information of Orphan Drugs
Table Manufacturing Equipment Suppliers of Orphan Drugs with Contact Information
Table Major Suppliers of Orphan Drugs with Contact Information
Table Key Consumers of Orphan Drugs with Contact Information
Figure Supply Chain Relationship Analysis of Orphan Drugs
Table New Project SWOT Analysis of Orphan Drugs
Table New Project Investment Feasibility Analysis of Orphan Drugs
Table Part of Interviewees Record List

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests,  Opport

2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests, Opport

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-company survey from VPGMarketResearch.com contains 1,650 pages and 890 tables. The report provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein ...

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.